The Big Ten Cancer Research Consortium (Big Ten CRC) arose from the fast-changing personalized medicine environment amid diminishing research opportunities for junior faculty and increasing demands to pre-screen large populations for the molecular subsets required for study eligibility.

The Benefits:

  • Expedited contracting by virtue of membership
  • Planned consolidated IRB review
  • Organized clinical trial working groups
  • Ability to share specimens with clinically annotated data
  • Avenue for development of junior faculty
  • Opportunity to quickly open trials across 11 academic institutions

Our Mission

The Big Ten cancer centers united to transform the conduct of cancer research through collaborative clinical trials and observational studies that seek to improve the lives of cancer patients in the diverse communities we serve by leveraging the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium (Big Ten CRC) creates a unique team research culture to drive science rapidly from ideas to treatment and prevention. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow.